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Available online 21 March 2015Abstract Human body is continuously exposed to different types of agents that results in the pro-
duction of reactive species called as free radicals (ROS/RNS) which by the transfer of their free
unpaired electron causes the oxidation of cellular machinery. In order to encounter the deleterious
effects of such species, body has got endogenous antioxidant systems or it obtains exogenous
antioxidants from diet that neutralizes such species and keeps the homeostasis of body. Any imbal-
ance between the RS and antioxidants leads to produce a condition known as ‘‘oxidative stress’’
that results in the development of pathological condition among which one is diabetes. Most of
the studies reveal the inference of oxidative stress in diabetes pathogenesis by the alteration in enzy-
matic systems, lipid peroxidation, impaired Glutathione metabolism and decreased Vitamin C
levels. Lipids, proteins, DNA damage, Glutathione, catalane and superoxide dismutase are various
biomarkers of oxidative stress in diabetes mellitus. Oxidative stress induced complications of dia-
betes may include stroke, neuropathy, retinopathy and nephropathy. The basic aim of this review
was to summarize the basics of oxidative stress in diabetes mellitus.
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Likewise Osteoporosis, Cushing’s syndrome and Scleroderma,
Diabetes mellitus is a group of metabolic disorders that is
characterized by elevated levels of glucose in blood (hyper-
glycemia) and insufﬁciency in production or action of insulin
produced by the pancreas inside the body (Maritim et al.,
2003). Insulin is a protein (hormone) synthesized in beta cells
of pancreas in response to various stimuli such as glucose,
sulphonylureas, and arginine however glucose is the major
determinant (Joshi et al., 2007). Long term elevation in blood
glucose levels is associated with macro- and micro-vascular
complications leading to heart diseases, stroke, blindness and
kidney diseases (Loghmani, 2005). Sidewise to hyperglycemia,
there are several other factors that play great role in patho-
genesis of diabetes such as hyperlipidemia and oxidative stress
leading to high risk of complications (Kangralkar et al., 2010).
2. Types of diabetes mellitus
Diabetes mellitus can be classiﬁed in different ways but one
form of classiﬁcation is as follow (American Diabetes
Association, 2004):
1. Type I diabetes (Insulin dependent) is due to immune
mediated beta-cells destruction, leading to insulin
deﬁciency.
2. Idiopathic diabetes is the type 1 diabetes with no known eti-
ologies and is strongly inherited.3. Type II diabetes (Non-Insulin dependent) is due to insulin
secretory defect and insulin resistance.
4. Gestational diabetes mellitus is any form of intolerance to
glucose with onset or ﬁrst recognition of pregnancy.
However diabetes is mostly classiﬁed basically into TWO
major types: Type I Diabetes (IDDM) and Type II Diabetes
(NIDDM).
3. Pathophysiology of diabetes
Whenever somebody takes the meal, there is rise in blood glu-
cose levels that stimulates insulin secretion resulting in an
increase in transportation, biotransformation and storage in
muscles and fat tissues. In fasting conditions, the glucose in
blood is provided by liver that is used by the brain, without
any dependency on insulin. Besides the storage of glucose,Figure 1 Pathophysiology of diabetes mellitus.
Diabetes mellitus and oxidative stress 549insulin also inhibits the secretion of glucagon and lowers the
concentration of serum fatty acids leading to a decline in liver
glucose production (Kangralkar et al., 2010). Insufﬁcient insu-
lin or resistance to insulin in the body results in reduced tissue
uptake of glucose that results in intracellular hypoglycemia
and extracellular hyperglycemia. The intracellular hypoglyce-
mia causes glucogenesis and gluconeogenesis that leads to fats
breakdown (causing diabetic ketoacidosis) and decreases pro-
tein synthesis and gamma globulins (causing cachexia,
polyphagia, and impaired wound healing), while the extra-
cellular hyperglycemia leads to hyperglycemic coma and osmo-
tic dieresis (Ozougwu et al., 2013) (see Fig. 1).
3.1. Pathogenesis of Type I diabetes mellitus (IDDM)
In Insulin dependent diabetes mellitus (IDDM) there is a deﬁ-
ciency of insulin secretion due to the autoimmune destruction
of beta pancreatic cells that leads to metabolic disturbances
associated with IDDM (Ozougwu et al., 2013). The end stage
of b-cell destruction represents the onset of clinical disease
leading to type 1 diabetes mellitus in which there are inﬁltrat-
ing monocytes, lymphocytes and a mixture of pseudoatrophic
islets with some cells secreting somatostatin, glycogen and pan-
creatic polypeptide which then, consequently through
immunogenic process, induces the disease (Al Homsi and
Lukic, 1992; Gill and Haskins, 1993; Yagi et al., 1992).
Autoimmunity, genetic makeup and environmental factors
are responsible for islets cell destruction (Michael et al., 2000).
3.2. Pathogenesis of Type II diabetes mellitus (NIDDM)
In Non-Insulin dependent diabetes mellitus (NIDDM) there
are certain mechanisms broken that keep regulation between
tissue sensitivity to insulin which consequently leads to
impaired insulin secretion by the pancreatic beta cells and
impaired insulin action through insulin resistance (Defronzo
and Lily, 1987). In this type of diabetes, multiple genetic
defects, and certain environmental factors especially obesity
are responsible for beta cell defects and peripheral tissue insu-
lin resistance respectively (Michael et al., 2000).Table 1 Complications of diabetes.
Acute complications (Metabolic) Chronic complications
(Systemic)
Infection (s) Blindness, retinopathy
Diabetic ketoacidosis (DKA) Neuropathy
Hyperglycemic, hyperosmolar, non-
ketonic coma
Atherosclerosis
Polydipsia, polyuria, fatigue, blurred
vision
Peripheral vascular
disease
Infection, amputation
Cerebrovascular disease
Macrovascular complications Microvascular
complications
Stroke Retinopathy and
cataracts
Heart disease and hypertension Renal disease
Peripheral vascular disease Neuropathy
Foot problems Foot problems4. Complications of diabetes
Diabetes is such a sort of disorder in which the patients are at
all the time on risk of complications. Complications may be
macrovascular (coronary heart disease, peripheral vascular
disease and stroke), microvascular (neuropathy, retinopathy
and nephropathy) and both micro- and macrovascular (dia-
betic foot). The mortality and morbidity of diabetes are associ-
ated more with macrovascular degeneration as compared to
the risks of microvascular complications in older people
(Wallace, 2004). In general, complications of diabetes mellitus
can be categorized into two groups (Wallace, 2004; Mohan,
2002) (see Table 1):
a. Metabolic acute complications: These are short term and
include hypoglycemia, ketoacidosis and hyperosmolar
non-ketonic coma.
b. Systemic late complications: These are long term chronic
sort of complications that include diabetic nephropathy,
microangiopathy, diabetic neuro- and retinopathy,
atherosclerosis and infections.
5. Overview of free radicals
5.1. Free radicals
Free radicals are reactive chemical entities that are short lived
species containing one or more unpaired electrons. They can
also be considered as necessary evil for signaling involved in
normal process of differentiation and migration. The free radi-
cals induce damage to cells by passing the unpaired electron
resulting in oxidation of cell components and molecules
(Bansal and Bilaspuri, 2011). They are generally very unstable
and very much reactive.
5.2. Types of free radicals
Free radicals can be classiﬁed into following three types:
1. Reactive oxygen species (ROS).
2. Reactive Nitrogen species (RNS) (Droge, 2011).
3. Reactive chlorine species (RCS) (Freidovich, 1999).
5.3. Biological roles of free radicals
As discussed earlier, free radicals are said to be necessary evil, as
they play role in origin and evolution of life. These are important
for activating different signaling pathways inside the cell, such
as the Mitogen activated protein kinase (MAPK) and extra-
cellular-signal-regulated kinase (ERK) pathways that alter gene
expression, as well as in coordinationwith superoxide dismutase
initiates cell death (Cho andWolkenhauer, 2003). For instance,
RNS produced by neurons act as neurotransmitters and those
generated by macrophages act as mediators of immunity.
These are also responsible for leukocyte adhesion, thrombosis,
angiogenesis and vascular tone. Similarly ROS is involved in
gene transcription, single transduction and regulation of other
activities in cell (Fang et al., 2002).
Table 2 Oxidative stress induced organ damage (Nosratola
et al., 2003).
Lungs Asthma, chronic bronchitis
Kidneys Glomerulonephritis, chronic renal failure
Joints Arthritis, rheumatism
Brain Alzheimer’s disease, Parkinson’s disease, memory loss,
depression, stroke
Eyes Cataract, retinal diseases
Fetus Preeclampsia, IU growth restriction
Heart
vessels
Arteriosclerosis, hypertension, ischemia,
cardiomyopathy, heart failure
Multi-
organs
Cancer, diabetes, inﬂammation infection, aging
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Both exogenous and endogenous substances produce free radi-
cals in cells and its surroundings. They can be produced from
non-enzymatic reactions of organic compounds with oxygen as
well as those initiated by ionizing radiations (Pham-Huy et al.,
2008). This process may also occur in mitochondrion by oxida-
tive phosphorylation. Different sources include radiations,
ROS, RNS, Neutrophils and macrophages production, chemi-
cals, smoking of cigarettes, beedi, cigars and industrial efﬂu-
ents (Sen et al., 2010). Now in order to scavenge the
deleterious effects of these free radicals, the body has different
mechanisms to produce antioxidants, endogenous or exoge-
nous, that will neutralize the elevated amount of free radicals
and keep the cells protected against their toxic effects and con-
tributing toward the prevention of diseases (Pham-Huy et al.,
2008) (see Fig. 2).
6. Oxidative stress and antioxidants
It is a universal truth that oxygen is the major factor that has
made the life ﬁnite. It is one of the important components of
aerobic life. However in some circumstances, this oxygen
may be a killer of cells when it generates reactive species that
causes necrosis and ultimately the cell death. RNS and RCS
also cause oxidation by the generation of certain mechanism
that interferes with the normal physiological processes inside
the cell (Weseler and Bast, 2010). ‘‘Oxidative stress’’ can be
deﬁned as any disturbance in the balance of antioxidants and
pro-oxidants in favor of the later due to different factors such
as aging, drug actions and toxicity, inﬂammation and/or
addiction (Sies, 1985). It is in general, excess formation
or/and insufﬁcient removal of highly reactive molecules such
as reactive nitrogen species (RNS) and reactive oxygen species
(ROS) (Johansen et al., 2005) Oxygen is highly reactive specie
that has the ability to become part of potentially harmful and
damaging molecules (Free Radicals). Oxidative stress causes
healthy cells of the body to lose their function and structure
by attacking them. Up until now, pathogenesis of about more
than 50 diseases has been implicated by free radicals (see
Table 2). It is when the antioxidant level is limited that thisFigure 2 Free radicalsdamage can become debilitating and cumulative (Mark
Percival, 1996). Damage to DNA, proteins, and other macro-
molecules due to oxidation has been implicated in the patho-
genesis of a wide variety of diseases, most notably cancer
and heart disease (Halliwell, 1994).
The term ‘‘antioxidant’’ can be labeled for any substance
whose availability, even in minute concentration inhibits or
delays the oxidation of a substrate. There are several species
or molecules, endogenous (internally synthesized) or exoge-
nous (consumed), that play a role in antioxidant defense and
may be considered as biomarkers of oxidative stress.
Antioxidants can be divided as either chain breaking antioxi-
dants or preventive antioxidants, based on their mechanism
of action (Somogyi et al., 2007). Different types of biological
antioxidants include, for instance, Glutathione (oxidized/re-
duced), Vitamin C & E, cystine, etc. (Savita Khanna 2000).
7. Oxidative stress in diabetes mellitus
It is believed that oxidative stress plays important role in the
development of vascular complications in diabetes particularly
type 2 diabetes (Pham-Huy, 2008). ROS level elevation in dia-
betes may be due to decrease in destruction or/and increase in
the production by catalase (CAT––enzymatic/non-enzymatic),
superoxide dismutase (SOD) and glutathione peroxidaseinduced cell injury.
Diabetes mellitus and oxidative stress 551(GSH–Px) antioxidants. The variation in the levels of these
enzymes makes the tissues susceptible to oxidative stress lead-
ing to the development of diabetic complications (Lipinski,
2001). According to epidemiological studies, diabetic mortali-
ties can be explained notably by an increase in vascular dis-
eases other than hyperglycemia (Pham-Huy, 2008).
7.1. Pathophysiology of oxidative stress in diabetes
Nowadays, evidences have been reported that support the role
of oxidative stress in the pathogenesis of both type 1 and type 2
diabetes. Free radical formation in diabetes by non-enzymatic
glycation of proteins, glucose oxidation and increased lipid
peroxidation leads to damage of enzymes, cellular machinery
and also increased insulin resistance due to oxidative stress
(Maritim et al., 2003). According to latest research, lipid is
not only but also the apolipoprotein component of LDL that
forms insoluble aggregates oxidatively due to hydroxyl radi-
cal-induced cross-linkage between apo-B monomers that is
responsible for oxidative damage in diabetic complications
(Pham-Huy, 2008). In diabetes mellitus, main sources of oxida-
tive stress are mitochondria. During oxidative metabolism in
mitochondria, a component of the utilized oxygen is reduced
to water, and the remaining oxygen is transformed to oxygen
free radical (O) which is an important ROS that is converted
to other RS such as ONOO, OH and H2O2 (Moussa, 2008).
Insulin signaling is modulated by ROS/RNS by two ways. On
one side, in response to insulin, the ROS/RNS are produced to
exert its full physiological function and on the other side, the
ROS and RNS have got negative regulation on insulin signal-
ing, interpreting them to develop insulin resistance which is a
risk factor for diabetes type 2 (Erejuwa, 2012).
7.2. Oxidative stress and diabetic complications
Many evidences from experiments have given link between dia-
betes and oxidative stress by measuring various biomarkers
that include DNA damage biomarkers and lipid peroxidation
products. It is believed that in the onset and progression of late
diabetic complication, free radicals have got a major role due
to their ability to damage lipids, proteins and DNA
(Ayepola, 2014). A variety of pathological conditions are
induced by oxidative stress such as Rheumatoid arthritis,
Diabetes mellitus and cancer (El Faramawy and Rizk, 2011).
Free radical and oxidative stress induced complications from
DM include coronary artery disease, Neuropathy, nephropa-
thy, retinopathy (Phillips et al., 2004) and stroke
(Asfandiyarova et al., 2007). In-vivo studies support the role
of hyperglycemia in the generation of oxidative stress leading
to endothelial dysfunction in blood vessels of diabetic patients
(Ceriello, 2006). Increase in the levels of glucose and insulin
along with dyslipidemia in patients suffering from diabetes
develops macroangiopathies that cause oxidative stress leading
to atherosclerosis (Giugliano et al., 1995).
7.3. Biomarkers of oxidative stress in diabetes mellitus
7.3.1. Proteins
ROS reacts with some amino acid in vitro, producing anything
from modiﬁed, denatured and non-functioning proteins that in
further may be responsible for oxidative stress (Nishigakiet al., 1981) Diabetic hyperglycemia, by the process of free
radical production, causes protein glycation and oxidative
degeneration. The degree of such protein glycation is estimated
by using some biomarkers such as glycated hemoglobin and
fructosamine levels. Alteration in function and structure of
antioxidant protein enzymes may also be due to nonenzymatic
glycation such that detoxiﬁcation of free radicals is effected
enhancing oxidative stress in diabetes (Maritim et al., 2003)
According to in vitro studies myeloperoxidase catalyzes the
conversion of L-tyrosine to 3,3-dityrosine which serves as a
crosslink between polypeptide chains of the same or different
proteins making it a convenient biomarker for protein oxida-
tion (Yla¨-Herttuala, 1999).
7.3.2. Lipids
Diabetes mellitus produces disturbances in the lipid proﬁle of
body making the cells more susceptible to lipid peroxidation
(Patricia, 2009). Experimental studies show that polyunsatu-
rated fatty acids in cell membrane are extremely prone to
attack by free radicals due to the presence of multiple bonds
(Butterﬁel et al., 1998). Lipid hyperperoxides (LHP) through
intermediate radical reactions produce such fatty acids that
generate highly reactive and toxic lipid radicals that form
new LHP (Matough et al., 2012). A critical biomarker of
oxidative stress is Lipid peroxidation which is the most
explored area of research when it comes to ROS (Hatice
et al., 2004). Malondialdehyde (MDA) is formed as a result
of lipid peroxidation that can be used to measure lipid perox-
ides after reacting it with thiobarbituric acid (Esterbauer et al.,
1991).
7.3.3. Vitamins
Vitamins are very important part of biological system as they
play important role in different biochemical processes. Among
such vitamins, Vitamin A, C and E act as antioxidants by
detoxifying the free radicals. Any alteration in their levels is
signiﬁcant biomarkers of oxidative stress. These vitamins also
promote toxicity by producing pro-oxidants in certain condi-
tions. Body levels of vitamin E have been reported to be either
increased or decreased by diabetes. However conﬂicting
reports present the deleterious effects of vitamin E on diabetes
induced vascular changes (Maritim et al., 2003).
7.3.4. Glutathione
Diabetes induces alterations in activity of enzymes glutathione
peroxidase and glutathione reductase. These enzymes are
found in cell that metabolizes peroxide to water and convert-
ing glutathione disulﬁde back into glutathione (Maritim
et al., 2003). Any alteration in their levels will make the cells
prone to oxidative stress and hence cell injury.
7.3.5. Catalase (CAT)
Catalase is regulator of hydrogen peroxide metabolism that
can, in excess, cause serious damage to lipids, RNA and
DNA. CAT converts H2O2 catalytically into water and oxygen
and thus neutralizes it. In case of catalase deﬁciency, beta cell
of pancreas that contain large amount of mitochondria, under-
goes oxidative stress by producing excess ROS that leads to
b-cells dysfunction and ultimately diabetes (Dana Jamieson,
1986). While investigating hyperglycemia-induced functional
552 U. Asmat et al.changes, hydrogen peroxide production, superoxide,
mitochondrial membrane polarization, and gene expression
ﬁngerprints of related enzymes in endothelial cells suggest that
hyperglycemia increased hydrogen peroxide production and
down-regulated CAT gene expression (Patel et al., 2013).
7.3.6. Superoxide dismutase (SOD)
Superoxide dismutase provides ﬁrst line defense against ROS
mediated cell injury by catalyzing the proportion of superoxide,
the primary ROS in oxygen metabolism, to molecular oxygen
and peroxide.We can say that superoxide is dismutated to other
compounds that are less toxic by SODs (Tiwari et al., 2013).
8. Conclusion
Oxidative stress has been demonstrated in many studies to par-
ticipate in the progression of diabetes which plays important
role during diabetes, including impairment of insulin action
and elevation of the complication incidence. Antioxidants have
already shown to be prospective in the treatment of diabetes
both type 1 and type 2. Increase in the levels of oxygen and
nitrogen free radicals (ROS/RNS) has been linked with lipid
peroxidation, non-enzymatic glycation of proteins and oxida-
tion of glucose which contributes toward diabetes mellitus
and its complications. Most of the studies have shown
relationship between oxidative stress and diabetes along with
their complications related to heart, liver kidney and eye.
Thus, oxidative stress seems to be more worrying in metabolic
disorders specially diabetes type 2.
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